4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0000905148-26-001862
Chief Financial Officer sold 7,842 shares at $5.18 ($40,658)
From the SEC's structured data for this filing
Trades in this filing
Gagnon Robert E. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-23 | Sale : show line 1 in the form | −7,842 | $5.18 | $40,658 | 592,158 | D |
| Open-market sales · 7,842 sh · avg $5.18 · $40,658 | ||||||
Loading xslF345X06/form4.xml…